Apogee Therapeutics (APGE) Q4 2023 Earnings

5MarConfirmed
Q4 2023
-0.65
-0.32
0.02
0.35

Details

Expected EPS
-0.65
Actual EPS
-0.65
Surprise EPS
0
Surprise Percent
+0%

Description

Apogee Therapeutics (APGE) has reported earnings of -0.65 per share for Q4 2023.

0 Comments

Share your thoughts